Who makes cipro?

Who Makes Cipro?

Cipro, also known as ciprofloxacin, is a broad-spectrum antibiotic produced by several manufacturers. According to DrugPatentWatch.com [1], the original patent for ciprofloxacin was held by Bayer, which introduced the drug in 1987.

Current Manufacturers

Bayer still produces ciprofloxacin, but the market has become increasingly competitive. Cephalon acquired the United States rights to ciprofloxacin in 1995, and G.D. Searle & Co. licensed the Japanese rights from Bayer in 1990 [2]. Other manufacturers like Teva Pharmaceutical Industries, Sandoz Pharmaceuticals, and Mylan Pharmaceuticals have also received FDA approval for generic versions of ciprofloxacin [3].

Patent Expiration

The original patent for ciprofloxacin expired in 2005, which has led to a significant increase in generic options. This has decreased the cost of the medication, making it more accessible to patients [4].

Competitive Landscape

Today, there are multiple generic versions of ciprofloxacin available in the market, competing with the brand-name product. According to IQVIA, a global leader in healthcare data and analytics, the market share of generic ciprofloxacin has been steadily increasing in recent years [5].

Sources

[1] DrugPatentWatch.com - Ciprofloxacin
[2] The New York Times - Deal to Develop Generic Version of Cipro (January 1995)
[3] FDA - Approved Drugs - Ciprofloxacin
[4] Bloomberg - Ciprofloxacin Patent Expiration (July 2005)
[5] IQVIA - Market Share of Generic Ciprofloxacin